
Sandoz Italia makes affordable medicines more accessible to patients worldwide. It operates as part of Sandoz Global with two main activities: generics and biosimilars, including standard generics and complex formulations. The company belongs to the pharmaceutical category and serves healthcare providers, hospitals, and pharmacies (B2B) with a focus on generic medicines and biosimilars. It serves about 500 million people each year and maintains a growing pipeline of 24 molecules. As a global leader in generics and biosimilars, it aims to expand access and address health challenges such as antimicrobial resistance.

Sandoz Italia makes affordable medicines more accessible to patients worldwide. It operates as part of Sandoz Global with two main activities: generics and biosimilars, including standard generics and complex formulations. The company belongs to the pharmaceutical category and serves healthcare providers, hospitals, and pharmacies (B2B) with a focus on generic medicines and biosimilars. It serves about 500 million people each year and maintains a growing pipeline of 24 molecules. As a global leader in generics and biosimilars, it aims to expand access and address health challenges such as antimicrobial resistance.